I am/have/had
I am looking for
Advanced Filters
Found 255 clinical trials
Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
This phase I/II trial studies the side effects and best dose of avelumab with M6620 in treating patients with deoxyribonucleic acid (DNA) damage repair (DDR) deficient solid tumors that have spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable). DDR deficiency refers to a …
BARD1
hysterectomy
dna damage
metastatic castration-resistant prostate cancer
hormonal contraception
- 0 views
- 16 Feb, 2024
- 1 location